The news is full of stories of sports-related concussions and how they impact health. Coaches and parents are going to great lengths to reduce student-athletes’ risk of brain injuries. However, a hidden danger lurks this time of year, and it can have an impact on the severity of a concussion or potentially “hide” a concussion.
In the peak of the summer and throughout the fall, heat is a problem for athletes. When players begin having two practices a day at the start of fall season sports, the risks increase exponentially. The issue is that the result of not hydrating and resting between practices can result in symptoms similar to that of a concussion making it difficult to differentiate between the two.
BETHESDA, MD. July 25, 2019 - BrainScope announced today that it has successfully completed a nearly five year, $9.9 million U.S. Department of Defense research contract supporting the development and validation of an objective marker of the presence and severity of concussion. In a large blinded validation study, the system demonstrated its ability to help clinicians assess concussion at the time of injury, reflect severity of injury, and aid in their assessment of readiness to return to activity. BrainScope extended the work performed under this Department of Defense contract to include adolescents funded through private investment from BrainScope and a second award from the NFL-GE Head Health Challenge I.
For Banner Health, one of the largest non-profit health system in the United States, finding ways to make health care easier and better for our patients is at the root of everything we do. That’s why we are making significant investments into the digital health and neurotech space, trying to answer some common pain points.
Let me give you an example.
Last year, Banner Urgent Care turned to an innovative device, BrainScope One, to provide better care and to help save patients money and time, as it helps clinicians identify traumatic brain injuries and concussions.
This is an area of growing concern. Statistics by the Centers for Disease Control and Prevention (CDC) show that there were approximately 2.5 million visits to emergency departments for traumatic brain injuries in 2014—an increase of 54% from 2006. Of those, roughly 812,000 were for children.
BETHESDA, MD. June 24, 2019 - BrainScope announced today the appointment of Susan Hertzberg as Chief Executive Officer. This is the 4th equity-backed venture that Hertzberg will helm. She is a proven commercial stage leader with an impressive track record of bringing innovative products and services to market and profitably scaling and delivering exceptional market growth.
In her new role, Hertzberg will drive the global strategy and commercialization of BrainScope’s traumatic brain injury (TBI) and concussion tools in the traditional healthcare, military and sports arenas and will expand the platform capabilities of its signature product Brainscope One to include objective assessments for brain diseases like depression and Alzheimer’s.
“BrainScope is growing rapidly given the high demand and need for non-invasive, point of care FDA-Cleared medical devices to objectively assess concussion and mild TBI,” said Founding CEO Michael Singer, who will move into the Executive Chairman role. “I am thrilled to have Susan join us and apply her unique talents and experience to scale our business and make these tools ubiquitous in the market. Her mission-driven, patient-centric approach and dynamic leadership style is a great fit and will help BrainScope reach its full potential for this very large market opportunity,” added Singer.
Traumatic brain injury (TBI) is a disturbance of normal brain functions due to a head injury that everyone is at risk. The Centers for Disease Control and Prevention (CDC) estimates that 138 people die each day in the U.S. due to injuries that include TBI. However, diagnosing TBI often involves unnecessary exposure to radiation from CT (computed tomography) scans. Recently published a few weeks ago in The American Journal of Emergency Medicine, a peer-reviewed publication, physicians at Washington University Barnes Jewish Medical Center in St. Louis found an over 30 percent reduction in unnecessary CT scans for TBI evaluations in emergency rooms using the recently FDA-approved medical device from BrainScope Company, Inc.—a medical neuro-technology company with various public sector and private sector funding, including venture capital from Revolution, founded by Steve Case, the co-founder of America Online (AOL).